This inventor holds 2 USPTO granted patents. Top assignees: Bristol-Myers Squibb, Bristol-Myers Squibb Compnay. Active years: 2006-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2007
Title: Unveiling the Innovations of Inventor Pamela M Carroll
Introduction:
Inventor Pamela M Carroll, based in Princeton, NJ, is a trailblazer in the field of molecular biology and genetic research, holding a total of 2 patents. Her groundbreaking work revolves around polynucleotides encoding Drosophila tumor necrosis factor (DmTNF) polypeptides and its variants, paving the way for significant advancements in the understanding of TNF signaling pathways.
Latest Patents:
Carroll's latest patents delve into the realm of DmTNF molecules, including two novel variants, DmTNFv1 and DmTNFv2. These patents encompass the encoding of polypeptides, fragments, and homologs of DmTNF, as well as the development of vectors, host cells, antibodies, and recombinant methods for their production. Her inventions also span screening methods for identifying agonists and antagonists of these polynucleotides, along with techniques for genetically modifying Drosophila or cultured cells to study DmTNF activity and modulators.
Career Highlights:
Throughout her career, Pamela M Carroll has contributed significantly to the field of molecular biology and genetics with her innovative research on DmTNF molecules. She has been associated with renowned companies like Bristol-Myers Squibb, where she continued to drive forward the boundaries of scientific exploration and discovery.
Collaborations:
Collaborating with esteemed colleagues such as Jian Chen and Chandra S Ramanathan, Carroll has fostered a network of shared knowledge and expertise. Together, they have propelled the field of genetic research forward, unraveling the complexities of TNF signaling and its implications.
Conclusion:
In conclusion, Pamela M Carroll's inventive spirit and dedication to molecular biology have solidified her position as a leading figure in genetic research. Her patents stand as a testament to her relentless pursuit of scientific excellence, shaping the landscape of TNF-related studies and opening new avenues for further innovation in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile